141 related articles for article (PubMed ID: 8709345)
1. Elevated estrogen receptor expression in human prostatic stromal cells by androgen ablation therapy.
Kruithof-Dekker IG; Têtu B; Janssen PJ; Van der Kwast TH
J Urol; 1996 Sep; 156(3):1194-7. PubMed ID: 8709345
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy.
Van der Kwast TH; Têtu B; Fradet Y; Dupont A; Gomez J; Cusan L; Diamond P; Labrie F
Prostate; 1996 Apr; 28(4):227-31. PubMed ID: 8602398
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor messenger RNA expression in human benign prostatic hyperplasia: detection, localization, and modulation with a long-acting gonadotropin-releasing hormone agonist.
Kirschenbaum A; Ren M; Erenburg I; Schachter B; Levine AC
J Androl; 1994; 15(6):528-33. PubMed ID: 7536725
[TBL] [Abstract][Full Text] [Related]
4. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate.
Adams JY; Leav I; Lau KM; Ho SM; Pflueger SM
Prostate; 2002 Jun; 52(1):69-81. PubMed ID: 11992621
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cells exposed to high concentrations of estradiol.
Smith P; Rhodes NP; Ke Y; Foster CS
Prostate Cancer Prostatic Dis; 2002; 5(2):105-10. PubMed ID: 12496997
[TBL] [Abstract][Full Text] [Related]
6. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia.
Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T
J Androl; 2009; 30(3):240-7. PubMed ID: 19136389
[TBL] [Abstract][Full Text] [Related]
8. Cycling activity of benign prostatic epithelial cells during long-term androgen blockade: evidence for self-renewal of luminal cells.
van der Kwast TH; Têtu B; Suburu ER; Gomez J; Lemay M; Labrie F
J Pathol; 1998 Dec; 186(4):406-9. PubMed ID: 10209490
[TBL] [Abstract][Full Text] [Related]
9. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
[TBL] [Abstract][Full Text] [Related]
11. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer.
Kuniyasu H; Chihara Y; Kondo H; Ohmori H; Ukai R
Oncol Rep; 2003; 10(6):1863-8. PubMed ID: 14534709
[TBL] [Abstract][Full Text] [Related]
12. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
14. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
15. [Total androgen blockade for prostate cancer].
Kagebayashi Y; Ozono S; Takashima K; Yoshikawa M; Hayashi Y; Kaneko Y; Maruyama Y; Hirao Y; Okajima E
Hinyokika Kiyo; 1997 Mar; 43(3):197-201. PubMed ID: 9127754
[TBL] [Abstract][Full Text] [Related]
16. Histopathological effects of androgen deprivation in prostatic cancer.
Civantos F; Soloway MS; Pinto JE
Semin Urol Oncol; 1996 May; 14(2 Suppl 2):22-31. PubMed ID: 8725888
[TBL] [Abstract][Full Text] [Related]
17. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
Scherr DS; Pitts WR
J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
[TBL] [Abstract][Full Text] [Related]
18. Localized amyloidosis of the seminal vesicle. Possible association with hormonally treated prostatic adenocarcinoma.
Unger PD; Wang Q; Gordon RE; Stock R; Stone N
Arch Pathol Lab Med; 1997 Dec; 121(12):1265-8. PubMed ID: 9431316
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
Fixemer T; Remberger K; Bonkhoff H
Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
[TBL] [Abstract][Full Text] [Related]
20. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
Gross M; Ramirez C; Luthringer D; Nepomuceno E; Vollmer R; Burchette J; Freedland SJ
Prostate; 2009 Apr; 69(5):520-7. PubMed ID: 19107851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]